Experimental Treatments Completed in Study for U.S. Veterans with PTSD

The Multidisciplinary Association for Psychedelic Studies (MAPS) has almost completed its study of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) to make MDMA-assisted psychotherapy a legal treatment approved by the U.S. Food and Drug Administration (FDA). On July 31, 2015, the 2nd experimental session was completed in a study of MDMA-assisted psychotherapy on 24 U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. On July 17, 2015, subject 19 out of 23 was treated in MAPS’ ongoing study of MDMA-assisted psychotherapy for subjects with PTSD from sexual assault, violent crime, war, natural disasters, or any other cause, taking place in Boulder, Colorado. https://www.maps.org/maps-media/update/5779-newsletter-august-7,-2015 Psychedelics have also been reported to treat alcoholism.